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ABSTRACT
Young convalescents aft er oncological treatment are at risk of toxic cardiomyopathy development. An 
evaluation of their capability to an exercise or sport needs examination of heart state. 
Goal of work: To evaluate the heart rate variability (HRV) analysis as a screening method in early diag-
nostics of toxic cardiomyopathy by patients aft er oncological chemotherapy in childhood.
Th e study was designed as an individual correlation test of HRV parameters to echocardiographical val-
ues. Probands: 85 girls and boys aft er oncological treatment by doxorubicin and/or cyclophosphamid; ag-
ing 7-29 years. Heart rate (beat to beat) was monitored during 5 minutes of vertical position, and in up-
right position. Th e echocardiographical measurement was performed in a rest and aft er dynamic exercise.
Th e values of the HRV parameters have no normal distribution. We found close relations of the rest ejec-
tion fraction to 3 HRV parameters – to spectral power of HF band in lying position, and to MSSD in lying 
and in stand-up position. Both of last HRV parameters represent above all a vagal activity. We found a close 
relation of aft er-stress ejection fraction to only one HRV parameter – to VLF/LF spectral power rate in ly-
ing position. Close relations were found in diff erence of the rest – aft er-stress EF (d-EF) to seven HRV pa-
rameters in lying position.
Th erefore we believe that HRV analysis, as an instrumental, timing and personal less demanding meth-
od, can be used for cardiomyopathy screening in oncological paediatric patients before exercise and sport 
practise.
ABSTRAKT
U mladých lidí po onkologické léčbě je riziko rozvoje kardiomyopatie. Posuzování jejich schopnosti k po-
hybové aktivitě vyžaduje také vyšetření stavu srdce. 
Cílem práce bylo posoudit analýzu variability srdeční frekvence (HRV) jako vyhledávací metodu toxické 
kardiomyopatie u pacientů po chemoterapii v dětství.
Ve studii je zjišťována korelace mezi parametry HRV a echokardiografi ckými hodnotami. Probandi: 85 
děvčat a chlapců po onkologické léčbě doxorubicinem a cyklofosfamidem, ve věku 7-29 let. Srdeční frek-
vence tep po tepu byla sledována během 5minutové polohy vleže a vstoje. Echokardiografi cké měření bylo 
provedeno v klidu a po dynamické zátěži.
Hodnoty HRV nemají normální rozložení. Nalezli jsme těsný vztah mezi klidovou ejekční frakcí a třemi 
parametry variability, spektrální výkon pásma HF vleže, MSSD vleže a vstoje. Oba poslední parametry 
reprezentují vagovou aktivitu. Zjistili jsme vztah pozátěžové ejekční frakce k poměru spektrálních výkonů 
VLF/LF vleže, a také mezi rozdílem klidové a pozátěžové ejekční frakce a sedmi parametry HRV vleže.
Domníváme se, že analýza HRV, technicky, časově a personálně méně náročná metoda, by mohla být 
používána ve vyhledávání kardiomyopatie u onkologických pacientů před započetím jejich sportovní 
aktivity.
Keywords: heart rate variability, cardiomyopathy, oncological therapy, exercise, sport.
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INTRODUCTION
Lately a number of young convalaescents aft er successful oncological treatment, and that wants come-
back to the full life activity, grow. An evaluation of their capability to an exercise or sport needs peri-
odical examination of heart state because the children aft er oncological treatment are at risk of toxic 
cardiomyopathy. Anthracyclins, above all doxorubicin and daunorubicin, are components of the thera-
peutic protocols of paediatric malignity. Nevertheless cardio toxicity is a risk of the treatment. Th e tox-
ic cardiopathy can arise immediately or more years aft er anthracyclin application (Schneider et al. 2003). 
Moderate endurance training is for the patients important because the exercise can prevent doxorubicin-
induced mitochondropathy and reduce the development of cardiac apoptosis (Ascensão et al. 2008). 
A proper diagnostic method of the cardiopathy is echocardiography (Bossi et al. 2001, Elbl et al. 2001, 
Hauser et al. 2001). Th e question of a diagnostic use of heart rate variability (HRV) analysis in cardio-
myopathy, as a toxic side eff ect of oncological therapy in childhood, has not been solved yet suffi  cient-
ly. An additional reason of our searching was a requirement of early diagnostics of the cardiomyopathy, 
in its sub-clinic stage. Physiological studies have already brought for many years a piece of knowledge 
about heart rate variability (HRV) (Ganong 1999, Honzíková 1990). It seems that the principal role of 
this regulation is in the neural autonomic centres. Its activities depend on a lot of physical and chemi-
cal, endogenous and exogenous factors (Task Force 1996). Pathological functional disorders of a cardi-
ovascular, neural, endocrinological, respiratory and other system imprint to HRV changes (Havorka et 
al. 2008). Th en the HRV analysis has diagnostic value in the medical fi elds, above all in cardiology, ne-
onatology, diabetology and neurology (Havorka et al. 2008, van Ravenswaaij-Arts et al. 1993, Štejfa et al. 
1998). It has no ability to separate a kind of cell damage, but it can contribute to evaluation of damage lev-
el. Th e cardiologic application of HRV analysis help to solve the problems of  transplanted heart rejection, 
death risk level determination by patients aft er heart attack, evaluation of myocardial damage in cardio-
pathy and others (Bonaduce et al. 1997, Doven et al. 2001). A 24-hours HRV was analysed for prediction 
of ventricular arrhytmias in idiopathic dilated cardiomyopathy (Grimm et al. 2003, Grimm et al. 2005, 
Hofmann et al. 1996, Palacios et al. 2007).  Mörner et al. (2005) assessed parasympathetic dysfunction in 
hypertrophic cardiopathy by HRV analysis of short-time and 24-h ECG records. Th e untreated patients 
were lower HRV than treated with beta-blockade. 
Th e HRV analysis as diagnostic method is non-specifi c, but very sensitive (Babcock et al. 1996).
Aim of the study: 
To evaluate the HRV analysis as a screening method of early toxic cardiomyopathy diagnostics by 
young oncological patients before their exercise and sport participation.
PATIENTS AND METHODS
Th e study was designed as a correlation test of HRV parameters to echocardiographical values that is 
reference diagnostic method.
Th e study group:
We have tested eighty fi ve patients (39 girls and 46 boys) aft er oncological treatment of acute leukae-
mia, Hodgkin’s disease, and others by doxorubicin and or cyclophosphamid. 
Aging of the patients was 7-29 years (=17,4; s = 5,1). Th e period between the examination and the treat-
ment was 1-26 years (= 8,9; s = 5,4). 
In examination time the probands had not get health complications (infection, cardiovascular, clas-
sic heart arrhythmia (ectopic beats, blocks). Th ere were no clinical symptoms of cardiomyopathy found-
ed by these children.
Th e heart rate variability measurement and analysis:
Heart rate (HR) like R-R intervals were measured by method beat to beat in short-term electrocardi-
ographical (ECG) record during a rest (aft er previous lull  in lying position when HR was no longer de-
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creasing, minimally 5 minutes) 5 minutes in lying position, and than 5 minutes in standing position. Th e 
examines were pursued between 8,00 and 12,00 a.m. in ambulatory care centre of paediatric clinic in the 
standard conditions (temperature 22-26oC, humidity 40-80%). It was used the VariaCardio TF4 system 
(SIMA Media Olomouc) with sampling frequency 1000 Hz. Th e sensor is in thoracic elastic band with 
two electrodes (load system CC5) and radio-transmitter. Th e ECG potential was transported to a receiv-
er connecting to computer. Th e system is supported by the soft ware for the monitoring and for the time 
and spectral (the fast Fourier transformation) analysis of R-R intervals (van Ravenswaaij-Arts et al. 1993). 
Th e system shows the supervisory ECG curve during measurement.  
Th ere was measured and or calculated 19 HRV parameters for lying position, 10 for standing position, 
and 7 for a relation lying/standing (Tab.1). Th eir values were compared with 3 selected echocardiograph-
ical parameters (Tab.1). Th e relative parameters (% of reference values) were related to HRV analysis by a 
healthy population (Novotný et al. 1998). Spectral parameters were calculated for three frequency bands: 
very low frequency 0-0,05 Hz (VLF), low frequency 0,05-0,15 Hz (LF), high frequency 0,15-0,5 Hz (HF). 
Th e dynamic echocardiographical measurement:
A bicycle ergometer Ergoline 400 was used for the dynamic exercise (25 W + 25W per 2 min to exhaus-
tion). Th e echocardiographical measurement (4 standard profi le of left  ventricle) was done before and im-
mediately aft er the stress, both in a lying position. For the ejection fraction assessment we used classical 
indicators from M-mode (Babcock et al. 1996). 
Statistical data processing:
For a correlation testing between HRV and echocardiographical values we have used the Spearman 
rank correlation test, and the multiple linear regression tests.
Table1: List of heart rate variability and echocardiographical parameters
Heart rate variability parameters
l-TP Total spectral power in lying position (ms2)
l-VLF Spectral power of very low frequency in lying position (ms2)
l-1LF Spectral power of low frequency in lying position (ms2)
l-1HF Spectral power of high frequency in lying position (ms2)
l-VLFnu Spectral power of very low frequency in lying position (n.u.)
l-LFnu Spectral power of low frequency in lying position (n.u.)
l-HFnu Spectral power of high frequency in lying position (n.u.)
l-TP% Total spectral power in lying position (% of reference)
l-VLF% Spectral power of very low frequency in lying position (% of reference)
l-LF% Spectral power of low frequency in lying position (% of reference)
l-HF% Spectral power of high frequency in lying position (% of reference)
l-VLF/LF Spectral power rate of VLF and LF in lying position
l-VLF/HF Spectral power rate of VLF and HF in lying position
l-LF/HF Spectral power rate of LF and HF in lying position
l-VLF/LF% Spectral power rate of VLF and LF in lying position (% of reference)
l-VLF/HF% Spectral power rate of VLF and HF in lying position (% of reference)
l-LF/HF% Spectral power rate of LF and HF in lying position (% of reference)
l-MSSD Square root of mean of sum of squares of diff erences between adjacent R-R intervals in lying position (ms2)
l-MSSD% Square root of mean of sum of squares of diff erences between adjacent R-R intervals in lying position (% of reference)
s-TP Total spectral power in stand-up position (ms2)
s-VLF Spectral power of very low frequency in stand-up position (ms2)
s-LF Spectral power of low frequency in stand-up position (ms2)
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Heart rate variability parameters
s-HF Spectral power of high frequency in stand-up position (ms2)
s-LF% Spectral power of low frequency in stand-up position (% of reference)
s-HF% Spectral power of high frequency in stand-up position (% of reference)
s-VLF/LF Spectral power rate of VLF and LF in stand-up position
s-VLF/HF Spectral power rate of VLF and HF in stand-up position
s-LF/HF Spectral power rate of LF and HF in stand-up position
s-MSSD Square root of mean of sum of squares of diff erences between adjacent R-R intervals in stand-up position (ms2)
s/l-VLF Lying/stand-up rate of spectral power of very low frequency (ms2)
s/l-LF Lying/stand-up rate of spectral power of low frequency (ms2)
s/l-HF Lying/stand-up rate of spectral power of high frequency (ms2)
s/l-VLF/LF Lying/stand-up rate of spectral power rate VLF/LF
s/l-VLF/HF Lying/stand-up rate of spectral power rate VLF/HF
s/l-LF/HF Lying/stand-up rate of spectral power rate LF/HF
s/l-MSSD Lying/stand-up rate of MSSD
Echocardiographic parameters
R-EF Rest left  ventricle ejection fraction in lying position (%)
S-EF Aft er-stress left  ventricle ejection fraction in lying position (%)
d-EF [Rest] – [aft er-stress] diff erence of ejection fraction (% of k-EF)
RESULTS
We bring the results of the Spearman rank tests of correlation of HRV to echocardiographical param-
eters. We assume that results are the most relevant. At the next tables (Table 2) we choose only statisti-
cal signifi cant cases.
Table 2:  Th e selected statistically signifi cant cases of the Spearman rank correlation test between the 
HRV and echocardiographical parameters.
R p-level
R-EF & l-HF% -0,223879 0,040638
R-EF & l-MSSD% -0,291781 0,007081
S-EF & l-VLF/LF -0,247435 0,022425
d-EF & l-HF 0,226608 0,037024
d-EF & l-HF% 0,258456 0,017607
d-EF & l-VLF/HF -0,317197 0,003097
d-EF & l-VLF/HF% -0,308171 0,004114
d-EF & l-VLF/LF -0,213912 0,049323
d-EF & l-RR 0,222628 0,040568
d-EF & l-MSSD 0,261477 0,015640
d-EF & l-MSSD% 0,323970 0,002645
R-EF & s-RR -0,231355 0,033138
R-EF & s-MSSD -0,342805 0,001320
d-EF & s-RR 0,305956 0,004405
Legend: Th e HRV and sonographic symbols are explained in Table 1.
R – Spearman rank correlation coeffi  cient, p – level of statistical probability.
However we did not fi nd out a signifi cance of the Spearman test of a correlation between stand up HRV 
spectral analysis parameters and S-EF, and stand up/lying HRV rate and S-EF and or d-EF.
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We present statistically signifi cant results of the multiple linear regression tested at the Table 3.
Table 3:  Th e selected statistically signifi cant results of the multiple linear regression of the relationship 
between the HRV and echocardiographical parameters.
B SE p-level
R-EF & l-HF% -0,26676 0,106378 0,014178
R-EF & s/l-VLF 0,460659 0,036206 0,000000
R-EF & s/l-LF 0,086027 0,017655 0,000005
R-EF & s/l-MSSD 0,692799 0,144174 0,000007
R-EF & l-HF% -0,21257 0,102794 0,042006
R-EF & s-HF -0,00178 0,000545 0,001593
S-EF & s-HF -0,00160 0,000784 0,044276
S-EF & s/l-MSSD -2,03238 0,731282 0,006789
S-EF & l-MSSD% 0,44121 0,197197 0,028113
S-EF & s-LF 0,00213 0,000890 0,019004
l-HF% & z-EF -2,15944 0,96691 0,028320
l-HF% &d-EF 1,42054 0,60686 0,021732
l-MSSD% & R-EF 5,8123 1,22196 0,000009
l-MSSD% & S-EF -5,2640 1,02057 0,000002
l-MSSD% & d-EF 3,5100 0,64053 0,000000
s/l-VLF/HF & R-EF 18,669 8,8430 0,037840
s/l-VLF/HF & S-EF -15,833 7,3886 0,035123
s/l-VLF/HF & d-EF 9,605 4,6331 0,041335
Legend: Th e HRV and sonographic symbols are explained at Table 1. Independent variables are in the left  
side of the fi rst column; dependent variables are in the right side of the fi rst column; B - regression coef-
fi cient; SE – standard error, p – level of statistical probability. 
DISCUSSION
During the Spearman rank correlation analysis we found the close relations of the rest ejection fraction 
to three HRV parameters – to spectral power of HF band in lying position, and to MSSD in lying and in 
stand-up position. Both of last HRV parameters represent above all a vagal activity.
We recognized the close relation of aft er-stress ejection fraction to only one HRV parameter – to VLF/
LF spectral power rate in lying position.
Th e close relations were found in  diff erence of the rest and aft er-stress EF to seven HRV parameters in 
lying position –  four parameters of short-time variability (spectral power of HF band, and MSSD in ab-
solute alike in relative values), and two parameters of spectral power rate – VLF/HF and VLF/LF.
A majority of signifi cant correlations are in lying position – ten cases; only one signifi cant case is in 
stand-up position. Th e stand-up/lying rate of HRV parameters do not show a statistical signifi cant rela-
tion to the echocardiographic parameters.
In accessible literature we did not fi nd comparable studies with the same aging profi le of probands, 
with the same method of HRV analysis. Partially and indirectly we can compare our results with experi-
ences of Walichiewicz´ s team (1998). Th ey found a close relation between echocardiographic parameters 
and HRV values of long-time ECG record (24 hours) by adults with dilated cardiomyopathy. Grimm et al. 
(1998) found a similar negative relationship of LVEF to HRV indicator of parasympathetic activity by pa-
tient idiopathic dilated cardiomyopathy, but their HRV analysis was from 24-h ECG recording. Folino et 
al. (2002) described a signifi cant correlation of 24-h HRV indicator (SDNN) to right as well as to left  ven-
tricular ejection fraction by patients with arrhytmogenic right ventricular cardiomyopathy. 
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Aft er the regress and correlation analysis we suppose that the low reliability values probably result 
from large inter-individual variance. Th ese results indicate, that the correlations are not only linear, but 
frequently exponential or polynomial (2nd level). Among  the most interesting 15 trends the short-time 
HRV parameters (HF, MSSD) are dominant, in lying alike stand-up position.
Due to the results of the multiple linear regression tests we conjecture that the most frequent HRV in-
dicators with close relation to ultrasonographic parameters are absolute and relative values of short-time 
variability (HF band). Th e parameters of the time domain analysis of R-R intervals (MSSD) have got a 
similar relation. One is resulted form a similar physiological consequences (subordination to vagal cen-
tre). Both of them present the interesting relation to ejection fraction, in lying alike stand-up position.
Th is facts lead to supposition, that HRV analysis HRV can be more sensitive indicator of a heart func-
tion worsening than echocardiographic parameters. We must not overrate this assumption, because 
HRV, due to complicated regulatory mechanism, is maybe more connected to neural (Jimenez et al. 
1998, Shiigi et al. 1998), respiratory, endocrine and metabolic functions than echocardiographic param-
eters that are maybe determined mainly by heart state.
Conclusions
With 85 young oncological convalaescents before exercise and sport participation we found next pieces:
Th e values of the HRV parameters have no normal distribution.
Th e basic rest and stress functional echocardiographical parameter (ejection fraction) signifi cant cor-
relate to heart rate variability parameters from short-time record (5 minutes).
Th e dominant relations are between the rest - aft er loading diff erence of the EF to short-time HRV pa-
rameters (HF-band spectral power, MSSD) in lying and stand-up position.
Th erefore we believe that HRV analysis, as an instrumental, timing and personal less demanding 
method, can be used for cardiomyopathy screening in subclinical stage by persons aft er oncological car-
diotoxic chemotherapy. 
For the HRV analysis using as cardiological screening of children before exercise or sport activity, we 
recommend to evaluate measuring results by every patient this way: 
If a short-time variability parameters (HF, MSSD) will be lower then 25th percentile of the reference 
(Novotný et al. 2008) then next care and examines are needed (echocardiography and others).
 Using of the other HRV parameters can fortify predicting and diagnostic capability of HRV analysis. 
For example there are parameters with the relation to ejection fraction (VLF/LF and VLF/HF rates in ly-
ing position and others). Th e system for HRV analysis facilitates their automatic calculation. Values of 
these parameters higher than 75th percentile of reference are suspected.
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